We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Identify Endocannabinoid Signaling as a Pharmaceutical Target for Obesity

News   Jan 12, 2017 | Original Source From University of California Riverside

 
Researchers Identify Endocannabinoid Signaling as a Pharmaceutical Target for Obesity
 
 
Advertisement
 

RELATED ARTICLES

How Parkinson's Protein Destroys Cell Membranes

News

A newly developed method has revealed how the composition of cell membranes seems to be a decisive factor for how small quantities of α-synuclein cause damage.

READ MORE

Why ApoE4 Is a Risk to the Brain

News

A group of researchers has discovered how ApoE4, considered to be the most important genetic risk factor for Alzheimer’s disease, can damage the brain.

READ MORE

Atomic Structure of Aβ Protein Assemblies Revealed

News

Researchers have revealed, for the first time, the atomic structure of amyloid-beta (Aβ) protein assemblies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE